Treatment of infertility in women

Journal of the American Pharmacists Association

Volumn 52, Issue 4, 2012, Pages

  Smith, Carriann ^a   Grimm, Maureen ^a,b   Schwegel, Megan ^a  

^a BUTLER UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Infertility; Pharmacy services; Pregnancy; Reproduction; Women's health

Indexed keywords

ACETYLSALICYLIC ACID; ANASTROZOLE; ARPIRIN; BROMOCRIPTINE; CABERGOLINE; CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; ESTRADIOL; FOLLISTIN; FOLLITROPIN; GANIRELIX; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; INHIBIN; LETROZOLE; METFORMIN; MONOAMINE OXIDASE INHIBITOR; MUELLERIAN INHIBITING FACTOR; NAFARELIN; NAFARELIN ACETATE; PROGESTERONE; PROTEINASE INHIBITOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; RIVAROXABAN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SILODOSIN; THYROTROPIN; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROFOLLITROPIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ALCOHOL CONSUMPTION; ARTHRALGIA; BACKACHE; BLEEDING; BLOATING; BODY TEMPERATURE; BONE PAIN; BREAST TENDERNESS; CONSTIPATION; CYANOCOBALAMIN DEFICIENCY; DEPRESSION; DIAGNOSTIC PROCEDURE; DIAPHORESIS; DIARRHEA; DISORIENTATION; DIZZINESS; DNA DAMAGE; DROWSINESS; DRUG INDUCED HEADACHE; EDEMA; ENDOMETRIOSIS; EVENING DOSAGE; FATIGUE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FLATULENCE; FLUID RETENTION; FLUSHING; HEALTH CARE QUALITY; HOT FLUSH; HUMAN; HYPERPROLACTINEMIA; HYPOGLYCEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPY; INDIGESTION; INJECTION SITE PAIN; INJECTION SITE REACTION; INTRACYTOPLASMIC SPERM INJECTION; IRRITABILITY; LACTIC ACIDOSIS; LIVER FAILURE; LUNG DISEASE; MENSTRUAL IRREGULARITY; MORNING DOSAGE; MUSCLE WEAKNESS; NAUSEA; OVARY CYST; OVARY HYPERTROPHY; OVARY INSUFFICIENCY; OXIDATIVE STRESS; PAIN; PATIENT COUNSELING; PHARMACIST; PHARMACIST ATTITUDE; PREMATURE AGING; REPRODUCTION; REVIEW; RHINITIS; SECONDARY AMENORRHEA; SIDE EFFECT; SMOKING; SOMNOLENCE; TACHYCARDIA; THROMBOEMBOLISM; TRANSVAGINAL ECHOGRAPHY; UNITED STATES; VAGINA BLEEDING; VISUAL DISORDER; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WOMEN'S HEALTH; COUNSELING; FEMALE; INFERTILITY; METHODOLOGY;

COUNSELING; FEMALE; HUMANS; INFERTILITY; PHARMACISTS; UNITED STATES;

EID: 84871860644     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.12044     Document Type: Review

References (53)

1. Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Accessed at www.cdc.gov/nchs/data/series/sr-23/sr23-025.pdf, February 24, 2012.
2. Duwe KN, Reefhuis J, Honein MA, et al. Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004. J Womens Health. 2010;19:407-16.
3. Centers for Disease Control and Prevention. Reproductive health: infertility FAQs. Accessed at www.cdc.gov/reproductivehealth/Infertility, February 25, 2012.
4. American Pregnancy Association. Statistics: pregnancy. Accessed at www.americanpregnancy.org/main/statistics.html, February 25, 2012.
5. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
6. National Infertility Association. Infertility diagnosis. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis, March 29, 2011.
7. Healy DL, Trounson AO, Andersen AN. Female infertility: causes and treatment. Lancet. 1994;343:1539-44.
8. Clementini E, Palka C, Iezzi I, et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod. 2005;20:437-42.
9. Maheshwari A, Hamilton M, Bhattacharya S. Effect of female age on the diagnostic categories of infertility. Hum Reprod. 2008;23:538-42.
10. Kinney A, Kline J, Kelly A, et al. Smoking, alcohol and caffeine in relation to ovarian age during the reproductive years. Hum Reprod. 2007;22:1175-85.
11. Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod. 2002;17:921-5.
12. Peck JD, Leviton A, Cowan LD. A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update. Food Chem Toxicol. 2010;48:2549-76.
13. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology. 1994;5:247-50.
14. Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod Biomed Online. 2006;12:542-51.
15. Green BB, Daling JR, Weiss NS, et al. Exercise as a risk factor for infertility with ovulatory dysfunction. Am J Public Health. 1986;76:1432-6.
16. National Infertility Association. Additional testing for females. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis/ additional-testing-for-females.html, January 4, 2012.
17. Jirge PR. Ovarian reserve tests. J Hum Reprod Sci. 2011;4:108-13.
18. National Infertility Association. Evaluating your reproductive organs. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis/ evaluating-your-reproductive-organs.html, January 4, 2012.
19. Kodaman PH, Arici A, Seli E. Evidence-based diagnosis and management of tubal factor infertility. Curr Opin Obstet Gynecol. 2004;16:221-9.
20. Grimbizis GF, Tsolakidis D, Anagnostou E, et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril. 2010;94:2720-5.
21. Clomid [package insert]. Bridgewater, NJ: Sanofi-Aventis; 2006.
22. Borglet LM, Calis KA, O'Connell MB, Smith JA. Infertility. In: Woman's health across the lifespan. Bethesda, MD: American Society of Health-System Pharmacists; 2010:339-52.
23. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril.2006;85:277-84.
24. Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008;14:571-82.
25. Casper R. Letrozole versus climiphene citrate: which is better for ovulation induction? Fertil Steril. 2009;92:858-9.
26. Badawy A, Shokeir T, Allam AF, Abdlhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol. 2009;88:187-91.
27. Elizur SE, Tulandi T. Drugs in infertility and fetal safety. Fertil Steril. 2008;89:1595-602.
28. Kiesel LA, Rody A, Greb RR, Szilagy A. Clinical use of GnRH analogues. Clin Endocrinol (Oxf). 2002;56:677-87.
29. Humaidan P, Quartarolo J, Papanikalaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94:389-400.
30. Follistim AQ (follitropin beta injection) [package insert]. Whitehouse Station, NJ: Schering-Plough; 2010.
31. Gonal F (follitropin alfa for injection) [package insert]. Rockland, MA: EMD Serono; 2009.
32. Bravelle (urofollitropin for injection) [package insert]. Parsippany, NJ: Ferring; 2008.
33. Rombauts L, Talmor A. Corifollitropin alfa for female infertility. Expert Opin Biol Ther. 2012;12:107-12.
34. de Lartigue J. Corifollitropin alfa: a new option to treat female infertility. Drugs Today (Barc). 2011;47:583-90.
35. Shoham Z, Smith H, Yeko T, et al. Recombinant LH (lutropin alfa) for the treatment of hypogonadotropic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol. 2008;69:471-8.
36. Menopur (menotropins for injection) [package insert]. Tarrytown, NJ: Ferring; 2010.
37. Repronex (menotropins for injection) [package insert]. Tarrytown, NJ: Ferring; 2001.
38. Coomarasamy A, Afnan M, Cheema D, et al. Urinary hMG versus recombinant FSH for COH following an agonist long down-regulatory protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23:310-5.
39. Al-Inany HG, Abou-setta AM, Aboulghar MA, et al. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis. Gynecol Endocrinol. 2009;25:372-8.
40. Lehert P, Schertz JC, Ezcurra D. Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reprod Biol Endocrinol. 2010;8:112.
41. Ovidrel (choriogonadotropin alfa injection) [package insert]. Rockland, MA: EMD Serono; 2010.
42. Devroey P, Abyholm T, Diedrich K, et al. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotropin releasing hormone antagonist ganirelix to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone. Human Reprod. 1998;13:3023-31.
43. Bakas P, Konidaris S, Liapis A, et al. Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation. Fertil Steril. 2011;95:2024-8.
44. Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876-80.
45. Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008;358:47-54.
46. Parlodel [package insert]. Suffern, NY: Novartis; 2006.
47. Xue T, Li SW, Wang Y. Effectiveness of bromocriptine monotherapy or combination treatment with clomiphene for infertility in women with galactorrhea and normal prolactin: a systematic review and meta-analysis. Curr Ther Res Clin Exp. 2010;71(4):199-210.
48. Kleinstein J, Luteal Phase Study Group. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Fertil Steril. 2005;83:1641-9.
49. Mitwally MF, Diamond MP, Abuzeid M. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2010;93:554-69.
50. Prometrium [package insert]. North Chicago, IL: Abbott; 2011.
51. Hsieh YY, Tsai HD, Chang CC, et al. Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study. J Assist Reprod Genet. 2000;17(3):174-7.
52. National Infertility Association. Donor options. Accessed at www.resolve.org/family-building-options/donor-options/donor-options.html, January 4, 2012.
53. Schering-Plough. GfK National survey complete results. Accessed at www.planforsomeday.com/survey.aspx, February 24, 2012.